EKSO BIONICS HOLDINGS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2012 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Ekso Bionics Holdings, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2012 to Q4 2024.
  • Ekso Bionics Holdings, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$3.41M, a 6.19% decline year-over-year.
  • Ekso Bionics Holdings, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$11.3M, a 25.5% increase year-over-year.
  • Ekso Bionics Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$11.3M, a 25.5% increase from 2023.
  • Ekso Bionics Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$15.2M, a 0.78% decline from 2022.
  • Ekso Bionics Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$15.1M, a 54.4% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$11.3M -$3.41M -$199K -6.19% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-03
Q3 2024 -$11.1M -$2.07M +$1.29M +38.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-28
Q2 2024 -$12.4M -$2.42M +$1.81M +42.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-10-28
Q1 2024 -$14.2M -$3.43M +$960K +21.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-10-28
Q4 2023 -$15.2M -$3.21M -$36K -1.13% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-03
Q3 2023 -$15.2M -$3.37M +$939K +21.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-28
Q2 2023 -$16.1M -$4.23M -$1.25M -42% Apr 1, 2023 Jun 30, 2023 10-Q 2024-10-28
Q1 2023 -$14.8M -$4.39M +$231K +5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-10-28
Q4 2022 -$15.1M -$3.18M -$315K -11% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-04
Q3 2022 -$14.8M -$4.3M -$2.35M -120% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 -$12.4M -$2.98M -$1.71M -134% Apr 1, 2022 Jun 30, 2022 10-Q 2023-10-26
Q1 2022 -$10.7M -$4.62M -$950K -25.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-10-26
Q4 2021 -$9.76M -$2.86M +$1.11M +28% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 -$10.9M -$1.96M -$4.41M -180% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$6.47M -$1.27M +$10.5M +89.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-03
Q1 2021 -$17M -$3.67M -$1.14M -44.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-03
Q4 2020 -$15.8M -$3.98M -$1.26M -46.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 -$14.6M $2.45M +$2.25M +1090% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$16.8M -$11.8M -$8.7M -284% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-02
Q1 2020 -$8.12M -$2.53M +$4.02M +61.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-02
Q4 2019 -$12.1M -$2.72M +$1.41M +34.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$13.5M $206K +$7.19M Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 -$20.7M -$3.07M +$4.91M +61.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-10-29
Q1 2019 -$25.6M -$6.55M +$1.35M +17.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-10-29
Q4 2018 -$27M -$4.13M +$4.85M +54% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$31.8M -$6.98M -$648K -10.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 -$31.2M -$7.98M -$2.47M -44.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-10-30
Q1 2018 -$28.7M -$7.9M +$403K +4.85% Jan 1, 2018 Mar 31, 2018 10-Q 2019-10-30
Q4 2017 -$29.1M -$8.98M -$3.4M -61% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-13
Q3 2017 -$25.7M -$6.34M +$2.14M +25.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$27.9M -$5.51M +$258K +4.48% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$28.1M -$8.3M -$4.65M -127% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q4 2016 -$23.5M -$5.58M -$931K -20% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-13
Q3 2016 -$22.5M -$8.48M -$3.29M -63.5% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-13
Q2 2016 -$19.2M -$5.77M -$120K -2.13% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-13
Q1 2016 -$19.1M -$3.65M +$464K +11.3% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-13
Q4 2015 -$19.6M -$4.65M +$15.5M +77% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 -$35.1M -$5.19M -$17.2M -143% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-15
Q2 2015 -$17.9M -$5.65M -$61.8M -110% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-15
Q1 2015 $43.9M -$4.12M +$77.7M +95% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-15
Q4 2014 -$33.8M -$20.2M -$14.1M -232% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-14
Q3 2014 -$19.7M $12M +$13.9M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-14
Q2 2014 -$33.6M $56.1M +$59.5M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-14
Q1 2014 -$93.1M -$81.8M -$78M -2054% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-14
Q4 2013 -$15.2M -$6.08M -$6.07M Oct 1, 2013 Dec 31, 2013 10-Q 2014-02-19
Q3 2013 -$9.09M -$1.89M -$1.89M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$7.2M -$3.4M +$1.5M +30.5% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-08
Q1 2013 -$8.69M -$3.8M +$860K +18.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q4 2012 -$9.56M -$1.78K* Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-19
Q3 2012 -$1.25K* Jul 1, 2012 Sep 30, 2012 10-Q/A 2013-11-18
Q2 2012 -$4.9M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-15
Q1 2012 -$4.66M Jan 30, 2012 Mar 31, 2012 10-Q/A 2013-11-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.